Thyrocare Technologies IPO – Snapshot, Prospectus, Allotment, Listing

thyrocare ipoThyrocare Technologies, a diagonatic company, is coming up with an IPO on April 27, 2016. The company has filed its Red Herring Prospectus (RHP) draft for initial public offering (IPO) with markets regulator Securities and Exchange Board of India (SEBI) to hit the capital market betweem Apr 27 and Apr 29, 2016. The price band is yet to be decided.

Company Profile

Thyrocare Technologies Limited is a diagnostics company which is incorporated on January 28, 2000 at Mumbai. The firm runs a diagnostic chains and conduct an array of medical tests and profiles of tests that center on early detection and management of disorders and diseases.

The firm operates and provides 192 tests and 54 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.

Their laboratory process over 30,000 sample and above 1 lakh investigations every day. Their profiles of tests include 17 profiles of tests administered under their ‘Aarogyam’ brand. Through wholly owned subsidiary, NHL, they operate a network of molecular imaging centers in New Delhi, Navi Mumbai and Hyderabad, focused on early and effective cancer monitoring.thyrocare ipo details

The company takes samples through a pan-India network of authorized service providers comprised of TAGs and TSPs, which operate under franchise agreements with it.  As of November 30, 2015, it had a network of 1,122 authorized service providers, comprised of 878 TAGs and 244 TSPs spread across 483 cities and 28 states and union territories.

Dr Lal PathLabs, SRL Diagnostics, Metropolis Healthcare and Apollo Clinic are the main competitors of the company. Most of the healthcare firms like Alkem Laboratories, Dr Lal PathLabs and Narayana Hrudayalaya had hit the capital market in the previous year. While, HealthCare Global Enterprises got listed on the stock exchanges last month.

Outlook of the company

  • Portfolio of specialized tests with an emphasis on wellness and preventive healthcare
  • Multi-lab model driving volume growth and economies of scale
  • Pan-India collection network supported by logistics capabilities and information technology infrastructure
  • Capital efficiencies in its diagnostic testing business
  • Experienced senior leadership and management team
  • Continue to develop its NHL business to provide affordable PET-CT scanning
  • Expand its service platform by developing new channels that leverage the strength of its brand and network

Purpose of the issue:-

  1. To enhance the brand name of the company.
  2. To avail liquidity of the company’s existing Shareholders.
  3. Carry out the sale of up to 10,744,708 Equity Shares by the Selling Shareholders.

Summary Of Issue:

Issue Open:- April 27, 2016 – April 29, 2016
Issue Type 100% Book Built Issue IPO
Issue Size (Shares) 10,744,708 Equity Shares of Rs. 10
Issue Size in (Value) Rs. [ ]Crore
Face Value Rs. 10 Per Equity Share
Issue Price Rs. 420 – Rs. 446 Per Equity Share
Market lots []Shares
Minimum Order Quantity []Shares
Listing At BSE, NSE

Promoters Of the Company:-

1) Dr. Velumani:-  He is the Chairman and Chief Executive Officer & Managing Director of the Company. He is a resident Indian national.

2) Dr. A. Sundararaju :- He is an Executive Director of the company. He is a resident Indian national.

 

Financials:-

Particulars For the year/Period ended (Rs. in Million)
Financial Year 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12 31-Mar-11
Total Liabilities 2943.71 2457.31 1965.35 1370.77 1009.14
Total Assets 2943.71 2457.31 1965.35 1370.77 1009.14
Total Revenue 1870.46 1565.55 1399.86 1141.85 812.07
Total Expenses 1175.04 876.60 741.12 621.72 435.80
Profit After Tax (PAT) 484.50 461.56 568.19 349.43 248.25

Subscription Figures

Number of Times Issue is Subscribed (BSE + NSE)

QIB    : 73.18 times

NII     : 225.3 times

RII     : 8.73 times

Total  : 73.55 times

Thyrocare Allotment Status

Thyrocare IPO allotment status would be available soon. Usually the allotment comes within a week from the closing date which in this IPO was April 29, 2016. The issue was over subscribed ~74 times thus one should not expect any big quantity of shares.

One can check the allotment on the below given link with PAN number or Application number or DP Client Id. All you need to do is to follow these steps

  1. Click on the given link See Thyrocare Allotment Status here
  2. Go to Application status
  3. Select IPO as Thyrocare
  4. Enter you PAN Number or Application Id or DP Client Id

It takes little time to fetch information so you need to be little patient.

Listing of Thyrocare IPO

The Listing of Thyrocare IPO is expected to be on May 06, 2016. The Scrip will get listed on both NSE and BSE.

Lead Manager Details:-

1) JM Financial Institutional Securities Limited

7th Floor, Cnergy Building,

Appasaheb Marathe Marg,Prabhadevi,

Mumbai 400 025

Tel: (91 22) 6630 3030

Fax: (91 22) 6630 3330

E-mail: thyrocare.ipo@jmfl.com

Investor Grievance E-mail:

grievance.ibd@jmfl.com

Website: www.jmfl.com

Contact Person: Lakshmi Lakshmanan

SEBI Registration No.: INM000010361

 

2) Edelweiss Financial Services Limited

14th Floor, Edelweiss House

Off C.S.T. Road Kalina,

 Mumbai 400 098

Tel: (91 22) 4009 4400

Fax: (91 22) 4086 3610

E-mail: tl.ipo@edelweissfin.com

Investor Grievance E-mail:

customerservice.mb@edelweissfin.com

Website: www.edelweissfin.com

Contact Person: Sandeep Maheshwari

SEBI Registration No.: INM0000010650

3) ICICI Securities Limited

ICICI Centre, H.T. Parekh Marg, Churchgate

Mumbai 400 020

Tel : (91 22) 2288 2460

Fax : (91 22) 2282 6580

E-mail: thyrocare.ipo@icicisecurities.com

Investor Grievance E-mail: customercare@icicisecurities.com

Website: www.icicisecurities.com

Contact Person: Amit Joshi/ Vishal Kanjani

SEBI Registration No.: INM000011179

Website: www.karisma.karvy.com

Contact Person: Rakesh Santhalia

SEBI Registration No.: INR000000221

 

Registrar Of The Company

Link Intime India Private Limited

C-13, Pannalal Silk Mills Compound

L.B.S. Marg Bhandup (West),

Mumbai 400 078

Maharashtra, India

Tel : (91 22) 6171 5400

Fax : (91 22) 2596 0329

E-mail: ttl.ipo@linkintime.co.in

Investor Grievance E-mail: ttl.ipo@linkintime.co.in

Website: www.linkintime.co.in

Contact Person: Shanti Gopalkrishnan

SEBI Registration No.: INR000004058

 

Registered Office:

D/37-1, TTC Industrial Area,

MIDC Turbhe, Navi

Mumbai 400 703;

Tel: (91 22) 2762 2762;

Fax: (91 22) 2768 2409

Contact Person: Ramjee Dorai, Company Secretary and Compliance Officer;

E-mail: ramjee.d@thyrocare.com;

Website: www.thyrocare.com;

Corporate Identity Number: U85110MH2000PLC123882

 

Like this Article? Subscribe to Our Feed!

One thought on “Thyrocare Technologies IPO – Snapshot, Prospectus, Allotment, Listing

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Out Best Brokerage Deals